These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3335865)

  • 1. Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity.
    McDonald JD; Cotton RG; Jennings I; Ledley FD; Woo SL; Bode VC
    J Neurochem; 1988 Feb; 50(2):655-7. PubMed ID: 3335865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphenylalaninemia in the hph-1 mouse mutant.
    McDonald JD; Bode VC
    Pediatr Res; 1988 Jan; 23(1):63-7. PubMed ID: 3340448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the genotype-phenotype relation in the hph-1 mouse mutant deficient in guanosine triphosphate (GTP) cyclohydrolase I activity.
    Maeda T; Haeno S; Oda K; Mori D; Ichinose H; Nagatsu T; Suzuki T
    Brain Dev; 2000 Sep; 22 Suppl 1():S50-3. PubMed ID: 10984661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin and biogenic amine metabolism in the hph-1 mouse.
    Hyland K; Gunasekera RS; Engle T; Arnold LA
    J Neurochem; 1996 Aug; 67(2):752-9. PubMed ID: 8764604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia.
    Niederwieser A; Blau N; Wang M; Joller P; Atarés M; Cardesa-Garcia J
    Eur J Pediatr; 1984 Feb; 141(4):208-14. PubMed ID: 6734669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal hyperphenylalaninemia presumably caused by guanosine triphosphate-cyclohydrolase deficiency.
    Dhondt JL; Farriaux JP; Boudha A; Largillière C; Ringel J; Roger MM; Leeming RJ
    J Pediatr; 1985 Jun; 106(6):954-6. PubMed ID: 3873535
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanosine triphosphate cyclohydrolase I deficiency: early diagnosis by routine urine pteridine screening.
    Naylor EW; Ennis D; Davidson AG; Wong LT; Applegarth DA; Niederwieser A
    Pediatrics; 1987 Mar; 79(3):374-8. PubMed ID: 3822637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
    Scherer T; Allegri G; Sarkissian CN; Ying M; Grisch-Chan HM; Rassi A; Winn SR; Harding CO; Martinez A; Thöny B
    J Inherit Metab Dis; 2018 Jul; 41(4):709-718. PubMed ID: 29520738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse.
    Nandi M; Miller A; Stidwill R; Jacques TS; Lam AA; Haworth S; Heales S; Vallance P
    Circulation; 2005 Apr; 111(16):2086-90. PubMed ID: 15824199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients].
    Dhondt JL; Hayte JM
    Ann Biol Clin (Paris); 2002; 60(2):165-71. PubMed ID: 11937441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sepiapterin and 6-acetyldihydrohomopterin on the guanosine triphosphate cyclohydrolase I of mouse, rat and the fruit-fly Drosophila.
    Jacobson KB; Manos RE
    Biochem J; 1989 May; 260(1):135-41. PubMed ID: 2775176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse.
    Khoo JP; Nicoli T; Alp NJ; Fullerton J; Flint J; Channon KM
    Mol Genet Metab; 2004 Jul; 82(3):251-4. PubMed ID: 15234340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.
    Jiang X; Liu H; Shao Y; Peng M; Zhang W; Li D; Li X; Cai Y; Tan T; Lu X; Xu J; Su X; Lin Y; Liu Z; Huang Y; Zeng C; Tang YP; Liu L
    Metabolism; 2019 May; 94():96-104. PubMed ID: 30742839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity.
    Harada T; Kagamiyama H; Hatakeyama K
    Science; 1993 Jun; 260(5113):1507-10. PubMed ID: 8502995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of HPH-1: a mouse mutant deficient in GTP cyclohydrolase I activity.
    Gütlich M; Ziegler I; Witter K; Hemmens B; Hültner L; McDonald JD; Werner T; Rödl W; Bacher A
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1675-81. PubMed ID: 7524491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions between GTP cyclohydrolase I and tyrosine hydroxylase in Drosophila.
    Krishnakumar S; Burton D; Rasco J; Chen X; O'Donnell J
    J Neurogenet; 2000 Apr; 14(1):1-23. PubMed ID: 10938545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrobiopterin biosynthesis, regeneration and functions.
    Thöny B; Auerbach G; Blau N
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):1-16. PubMed ID: 10727395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTP-cyclohydrolases: a review.
    Blau N; Niederwieser A
    J Clin Chem Clin Biochem; 1985 Apr; 23(4):169-76. PubMed ID: 3891906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo regulation of phenylalanine hydroxylase in the genetic mutant hph-1 mouse model.
    Gunasekera RS; Hyland K
    Mol Genet Metab; 2009 Nov; 98(3):264-72. PubMed ID: 19560382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the metabolism of the aromatic amino acid hydroxylase cofactor, tetrahydrobiopterin, in mutant mice with neurological and immunological defects.
    Duch DS; Bowers SW; Woolf JH; Davisson MT; Maltais LJ; Nichol CA
    Biochem Genet; 1986 Oct; 24(9-10):657-68. PubMed ID: 3778424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.